findmyKOL
Clinical trialNCT04720742WithdrawnPhase 2Interventional

Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation

SponsorIrsiCaixaEnrollment0HIV Infection
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Italy
  • Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico Di Milano

    Milan, Lombardy, Italy

Netherlands
  • University Medical Center Utrecht

    Utrecht, Netherlands

Spain
  • Complejo Hospitalario Universitario de Granada

    Granada, Andalusia, Spain

  • Hospital Gregorio Marañón

    Madrid, Spain

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2021
Primary completion
28 Mar 2022
Completion
28 Mar 2022
Last update posted
3 Aug 2022
Registered enrollment
0
Registry id
NCT04720742
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.